French Glendon E. III 4
4 · Pulmonx Corp · Filed Jan 21, 2025
Insider Transaction Report
Form 4
Pulmonx CorpLUNG
French Glendon E. III
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-01-16$6.53/sh−2,326$15,189→ 1,069,648 total - Sale
Common Stock
2025-01-17$6.50/sh−2,221$14,437→ 1,067,427 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.50 to $6.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.